New Step by Step Map For P-gb-IN-1
MI-CP151 was a stage 1b randomised, double-blind, placebo managed, dose-escalation, multicentre research To guage multiple intravenous doses of sifalimumab, in adult clients with dermatomyositis or polymyositis (NCT00533091). Major trial aims had been To guage the security and tolerability of sifalimumab in dermatomyositis or polymyositis individua